Yan-hong Deng

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.

Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.

Journal: Journal of surgical oncology

Published: June 18, 2021

Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study.

Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study.

Journal: American journal of cancer research

Published: May 05, 2020

Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer.

Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer.

Journal: NPJ precision oncology

Published: April 16, 2020

Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.

Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.

Journal: Cancer medicine

Published: July 12, 2019

Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial.

Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial.

Journal: Gastroenterology report

Published: July 08, 2019

Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.

Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.

Journal: The Lancet. Oncology

Published: December 28, 2017

Expert consensus on maintenance treatment for metastatic colorectal cancer in China.

Expert consensus on maintenance treatment for metastatic colorectal cancer in China.

Journal: Chinese journal of cancer

Published: October 26, 2015

Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.

Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.

Journal: Chinese journal of cancer

Published: April 23, 2015

Clinical value of MR diffusion weighted imaging in prediction of pathological complete response of rectal cancer after neoadjuvant therapy

Clinical value of MR diffusion weighted imaging in prediction of pathological complete response of rectal cancer after neoadjuvant therapy

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: December 27, 2013

Meta-analysis of efficacy and safety on neoadjuvant therapy for rectal cancer

Meta-analysis of efficacy and safety on neoadjuvant therapy for rectal cancer

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: November 23, 2012

Lymph nodes distribution and metastatic pattern of ultra-low rectal cancer after neoadjuvant therapy

Lymph nodes distribution and metastatic pattern of ultra-low rectal cancer after neoadjuvant therapy

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: October 27, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026